DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Levis M.
Midostaurin approved for FLT3-mutated AML.
Blood 2017;
129: 3403-3406 . doi:10.1182/blood-2017-05-782292
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.